Chimerix shares jumped sharply on Tuesday after the firm announced that it would be making changes to its executive team.
February 23, 2016: Here are four stocks trading with heavy volume among 46 equities making new 52-week lows today. PTC Therapeutics Inc. (NASDAQ: PTCT) dropped about 59% on Tuesday to post a new...
February 22, 2016: Here are four stocks trading with heavy volume among 27 equities making new 52-week lows today. Chimerix Inc. (NASDAQ: CMRX) dropped by about 39% on Monday to post a new 52-week...
Chimerix had a bad start to the week as it tumbled in early trading on Monday, following some late stage clinical trial results.
December 28, 2015: Here are four stocks trading with heavy volume among 34 equities making new 52-week lows today. Chimerix Inc. (NASDAQ: CMRX) dropped about 81% on Monday to post a new 52-week low...
Chimerix reported mixed fourth-quarter financial results before the markets opened on Monday.
One thing is for sure, the insiders continue to buy stock, and at these lofty levels, that remains a positive for investors.
Tuesday's top analyst calls were in shares of Albermarle, Atara Biotherapeutics, Chimerix, IHS, NetApp, Pure Storage and more.
Chimerix absolutely led the bears in Monday’s trading session on less-than-favorable results from a late-stage trial.
The top analyst upgrades, downgrades and initiations seen on Monday, February 22, include AbbVie, Deere, Expedia, Hewlett Packard Enterprise, JPMorgan and Phillips 66.
Although stocks are beginning to make a comeback, there are still those that are caught in the downturn slowing this recovery.
Thursday’s top analyst upgrades, downgrades and initiations include AK Steel, CVS Health, Micron Technology, Nike, Oracle, Pandora Media, Sunrun and US Steel.
Tuesday's top analyst upgrades, downgrades and initiations include AbbVie, CDW, CSC, Eli Lilly, Ericsson, Gold Fields, JD.com, Nokia and Rackspace.
These 50% to 100% implied upside picks from analysts are generally coming with far more risk than traditional Dow stocks, even if many of these are large cap stocks.
The sad news that Ebola patient Thomas Eric Duncan has died in a Dallas hospital now raises fears that Ebola drugs might not be a cure-all for patients.